e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mechanisms leading to the bronchoprotective effects of N-Acetylcysteine in human bronchi stimulated by lipopolysaccharide
L. Calzetta (Rome, Italy), P. Rogliani (Rome, Italy), F. Facciolo (Rome, Italy), B. Rinaldi (Naples, Italy), M. Cazzola (Rome, Italy), M. Matera (Naples, Italy)
Source:
International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Session:
Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Session type:
Poster Discussion
Number:
5253
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Calzetta (Rome, Italy), P. Rogliani (Rome, Italy), F. Facciolo (Rome, Italy), B. Rinaldi (Naples, Italy), M. Cazzola (Rome, Italy), M. Matera (Naples, Italy). Mechanisms leading to the bronchoprotective effects of N-Acetylcysteine in human bronchi stimulated by lipopolysaccharide. 5253
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Anti-inflammatory profile of N-acetylcysteine in human bronchi stimulated with lipopolysaccharide
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Concomitant exposure to nicotine and endotoxin in vitro induces murine airway hyperreactivity possibly via nicotine-induced upregulation of toll-like receptors
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
N-Acetylcysteine protects human bronchi via inhibiting neurokinin A
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017
The role of isoprenylation in lipopolysaccharide (LPS)-induced human airway hyperresponsiveness
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
Tiotropium inhibits acetylcholine-induced generation of proinflammatory microparticles by human pulmonary epithelial cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Inhibitory effect of statins on fibrogenic mediator production from lung cells
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012
Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003
Inhaled CCR1 antagonist AZD4818 reduces leucocyte influx in the rat lipopolysaccharide (LPS) lung inflammation model
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009
Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007
The effects of inhaled glucocorticoids on human neutrophil apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001
Modulatory effects of immunosuppressives on IL-8 and GM-CSF expression in bronchial and alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 854s
Year: 2006
Resveratrol is superior to dexamethasone in suppressing cytokine release from human airway smooth muscle cells exposed to lipoteichoic acid in COPD
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Formoterol protects against platelet-activating factor-induced effects in asthma
Source: Eur Respir J 2004; 23: 71-75
Year: 2004
Effects of thromboxane A2 receptor antagonists on airway mucus overproduction induced by cigarette smoke and lipopolysaccharide
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Airway hyperresponsiveness to histamine induced by repetitive intraperitoneal injection of lipopolysacharide and the involvement of nitric oxide generation in guinea pigs
Source: Eur Respir J 2005; 26: Suppl. 49, 367s
Year: 2005
Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Mechanisms of acetylcholine-induced release of proinflammatory extracellular vesicles by endothelial cells and inhibitory effects of tiotropium
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept